Sh. Jagdamba Pol (512453)

FairStock Score: 21/100 — RISKY

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Return on equity at 18.13% shows historically decent shareholder returns.
• ROCE of 22.49% indicates efficient capital deployment.
• Latest quarter remains profitable with ₹8 Cr net profit on ₹64 Cr sales.
• Book value of ₹297.98 provides a tangible asset base.
• Trailing P/E of 11.63 offers apparent cheapness if earnings recover.

Concerns

• Sales down 43.91% and profit down 38.48% reflect severe earnings deterioration.
• Piotroski F-Score of 3/9 and FairStock Score of 21/100 highlight poor financial health.
• Debt-to-equity and promoter holding are undisclosed, limiting transparency.
• Dividend yield of just 0.12% gives shareholders negligible income support.

AI Analysis

Looking at Sh. Jagdamba Pol, I am immediately cautious. The trailing P/E of 11.63 looks cheap, but that is a backward-looking number. Sales have collapsed by 43.91% and profits by 38.48%, with the latest quarter showing only ₹64 Cr of sales and ₹8 Cr of net profit. Annualised, that implies roughly ₹32 Cr of profits, making the effective forward P/E around 24 times — no longer the bargain it appears at first glance. The Piotroski F-Score of 3 out of 9 and FairStock Score of 21 out of 100 reinforce my warn: this is a financially weak business today, not a compounding machine. Nevertheless, the company is not bust. Return on equity is 18.13% and ROCE is 22.49%, so capital has been well deployed in the past. Book value stands at ₹297.98 per share, and the stock trades at 2.94 times that. With a negligible dividend yield of 0.12%, the shareholder is not being paid to wait. Debt-to-equity is not disclosed, and promoter holding is absent, adding layers of uncertainty. As a Graham-style investor, I would wait for the business to stabilise before considering an investment. I want to see the sales decline slow and profit margins recover, quarter after quarter. If this is a cyclical downturn, the company should eventually recover; but if it is a secular decline, the cheap valuation will only get cheaper. The prudent move is to sit on my hands and watch the next few earnings reports. The current price near the 52-week high of ₹997 suggests Mr. Market is hopeful, but hope is not a strategy. I'd prefer to miss the turnaround than to lose capital chasing a value trap. In the stock market, the patient investor is rarely left empty-handed; the impatient one often is.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer